Psychiatric health care provider attitudes towards implantable medication

被引:0
作者
Dankert, Mary E. [2 ]
Brensinger, Colleen M. [3 ]
Ralph, LaRiena N. [2 ]
Seward, Devon A. [2 ]
Bilker, Warren B. [3 ]
Siegel, Steven J. [1 ,2 ]
机构
[1] Univ Penn, Translat Res Labs, Stanley Ctr Expt Therapeut Psychiat, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Psychiat, Div Neuropsychiat, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA
关键词
Implant; Adherence; Treatment; Outcome; Attitudes; GENERALIZED ANXIETY DISORDER; SCHIZOPHRENIA; DELIVERY; RISPERIDONE; DEPRESSION; VALIDITY; OUTCOMES; INSIGHT;
D O I
10.1016/j.psychres.2008.12.012
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Medication nonadherence is a major problem in psychiatry. Introduction of implantable psychiatric medication could alleviate the need to take daily medication, significantly decreasing the rate of nonadherence. This survey assessed psychiatric health care professionals' opinions regarding implants. An email was sent to potential participants including an explanation of the study and a link to an online survey. Email addresses of faculty in the Department of Psychiatry were obtained from websites of United States medical schools. To assess which provider characteristics were most important in consideration of implants, logistic regression models were employed. For assessing which patient characteristics were associated with providers' opinions, logistic regression models using generalized estimating equations tested associations between patient factors and implant decision. Eighty-six percent of respondents supported implants for a subset of patients. Four provider characteristics influenced support for implants including type of work, caseload, percent of patients with schizophrenia and percent of patients with bipolar disorder. Seven patient characteristics significantly influenced provider opinions including illness severity, length of illness, medication compliance, diagnosis, type of medication, family support, and patient age. Although dozens of factors influence the future of implants, the surveyed population showed moderate to strong support for this novel treatment. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:167 / 171
页数:5
相关论文
共 30 条
  • [1] Systematic meta-review of depot antipsychotic drugs for people with schizophrenia
    Adams, CE
    Fenton, MKP
    Quraishi, S
    David, AS
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2001, 179 : 290 - 299
  • [2] Archer DF, 2002, FERTIL STERIL, V77, pS27
  • [3] Bunn MH, 1997, ARCH PSYCHIAT NURS, V11, P238
  • [4] Attitudes of patients and family members towards implantable psychiatric medication
    Dankert, Mary E.
    Brensinger, Colleen M.
    Metzger, Kayla L.
    Li, Chunbo
    Koleva, Svetlinka G.
    Mesn, Andrea
    Laprade, Batrice
    Wiguna, Tjhin
    Han, Changsu
    Farooq, Saeed
    Severusi, W. Emanuel
    GayareS, Jocelyn G.
    Langosch, Jens M.
    Lallart, Xavier
    Tateno, Masaru
    Mihai, Adriana
    Nair, Sudha R. N.
    Belmaker, Robert
    Rybakowski, Janusz
    Owe-Larsson, Bjoern
    Kane, John M.
    Johnstone, Eve C.
    Maclntyre, Donald J.
    Malhotra, Sameer
    Gonzdlez-Pinto, Ana
    Mosquera, Fernando
    Babb, Suzann M.
    Pour, Ehsan Habib
    Fatemi, Seyedeh Sedigheh
    Swanson, Charles
    Adler, Caleb
    Young, Allan
    Hoeft, Fumiko
    Sivakumar, Kandiah
    Radoeva, Petya D.
    Lallart, Elise A.
    Bilker, Warren B.
    Siegel, Steven J.
    [J]. SCHIZOPHRENIA RESEARCH, 2008, 105 (1-3) : 279 - 286
  • [5] Getting better, getting well - Understanding and managing partial and non-response to pharmacological treatment of non-psychotic major depression in old age
    Driscoll, Henry C.
    Karp, Jordan F.
    Dew, Mary Amanda
    Reynolds, Charles F., III
    [J]. DRUGS & AGING, 2007, 24 (10) : 801 - 814
  • [6] Improving medical care for persons with serious mental illness: Challenges and solutions
    Druss, Benjamin G.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 : 40 - 44
  • [7] Determinants of medication compliance in schizophrenia: Empirical and clinical findings
    Fenton, WS
    Blyler, CR
    Heinssen, RK
    [J]. SCHIZOPHRENIA BULLETIN, 1997, 23 (04) : 637 - 651
  • [8] Fox C, 1996, J Health Soc Policy, V8, P39, DOI 10.1300/J045v08n01_04
  • [9] Insight and its relationship to clinical outcomes in patients with schizophrenia or schizoaffective disorder receiving long-acting risperidone
    Gharabawi, Georges M.
    Lasser, Robert A.
    Bossie, Cynthia A.
    Zhu, Young
    Amador, Xavier
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2006, 21 (04) : 233 - 240
  • [10] Transdermal fentanyl in the long-term treatment of cancer pain: A prospective study of 50 patients with advanced cancer of the gastrointestinal tract or the head and neck region
    Grond, S
    Zech, D
    Lehmann, KA
    Radbruch, L
    Breitenbach, H
    Hertel, D
    [J]. PAIN, 1997, 69 (1-2) : 191 - 198